dr. barrientos discusses promising agents in cll
Published 5 years ago • 603 plays • Length 1:50Download video MP4
Download video MP3
Similar videos
-
1:59
dr. barrientos discusses combination strategies in cll
-
1:25
dr. barrientos on the challenges in cll
-
1:51
dr. barrientos on remaining challenges in cll
-
2:00
dr. barrientos discusses acalabrutinib in cll
-
1:47
dr. barrientos on the role of acalabrutinib in cll
-
1:34
dr. barrientos on the impact of combinations in cll
-
1:23
dr. barrientos discusses ibrutinib in elderly populations with cll
-
1:24
dr. barrientos on advances in the treatment landscape for patients with cll
-
8:33
other promising strategies in cll
-
0:43
using acalabrutinib in cll patients with ibrutinib intolerance
-
7:14
dr. jacquieline barrientos – hematologic, immunologic and patient for phase iii resonate study
-
1:38
dr. brander on targeted agents in cll
-
0:43
using acalabrutinib in the event of an intolerance to ibrutinib in cll
-
1:54
dr. fakhri on selecting the optimal treatment in cll
-
8:40
promising future leaders in cll research
-
1:28
dr. eradat discusses unmet needs in cll
-
12:15
challenges of selecting frontline therapy in cll
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll
-
1:39
dr. barrientos on the management of elderly patients with cll